• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

1-(Aminooxy)Propane Hydrochloride (CAS No. 6084-54-4): A Comprehensive Overview of Its Chemistry, Applications, and Emerging Research

The 1-(aminooxy)propane hydrochloride, identified by the CAS No. 6084-54-4, is a synthetic organic compound with significant applications in medicinal chemistry and biochemical research. Structurally characterized by an aminooxy group (-O-NH?) attached to a propane backbone, this compound exists as its hydrochloride salt form, stabilizing its chemical properties under physiological conditions. Recent advancements in its synthesis and functionalization have positioned it as a critical reagent in the development of targeted drug delivery systems and bioconjugate technologies.

In terms of chemical synthesis, the 1-(aminooxy)propane hydrochloride is typically prepared via nucleophilic substitution reactions involving propargyl alcohol derivatives. A study published in the Journal of Medicinal Chemistry (2023) highlighted an optimized protocol using microwave-assisted synthesis to enhance reaction efficiency and purity. This method reduces reaction time by over 60% compared to conventional approaches, underscoring its industrial scalability for large-scale production while maintaining compliance with Good Manufacturing Practices (GMP).

Beyond traditional synthesis, the compound’s unique reactivity has driven innovations in bioconjugation strategies. Researchers at Stanford University demonstrated its utility as a linker in antibody-drug conjugates (ADCs), where the aminooxy group enables efficient oxime bond formation with aldehyde-functionalized payloads. This mechanism was shown to improve drug stability during circulation while ensuring rapid cleavage at tumor sites under hypoxic conditions—a breakthrough reported in Nature Biomedical Engineering (2023). Such findings validate its role in next-generation ADC design targeting solid tumors.

In academic research, the CAS No. 6084-54-4-listed compound serves as a key intermediate for synthesizing fluorescent probes and imaging agents. A collaborative study between MIT and Harvard Medical School leveraged its reactivity to develop pH-sensitive nanoparticles for real-time monitoring of intracellular glucose metabolism (Science Advances, 2023). The probe’s selectivity stems from the protonation-dependent activation of its amine group, enabling precise spatiotemporal imaging without cytotoxic effects—a critical advancement for preclinical diagnostics.

Recent computational studies further illuminate its potential in materials science. Molecular dynamics simulations published in ACS Nano (2023) revealed that polymerized forms of this compound exhibit exceptional biocompatibility and mechanical resilience when incorporated into hydrogel scaffolds for tissue engineering. These polymers demonstrated self-healing properties under physiological conditions, suggesting applications in regenerative medicine where structural integrity is paramount.

Economic viability remains a focal point of ongoing research. A cost-benefit analysis conducted by the European Chemical Society (ECS) compared production methods across five continents, concluding that solvent-free synthesis pathways reduce environmental footprints by 35% while maintaining product quality (ECS Sustainable Chemistry Reports, Q3 2023). This aligns with global sustainability initiatives without compromising performance metrics critical to pharmaceutical applications.

Safety profiles derived from recent toxicology studies provide reassurance for clinical translation. Data from repeated-dose toxicity trials published in Toxicological Sciences (2023) showed no observable adverse effects at therapeutic concentrations up to 15 mg/kg/day in murine models—well within proposed dosing ranges for proposed therapeutic uses. These results support progression into Phase I clinical trials for oncology indications currently under regulatory review.

The compound’s structural versatility continues to inspire interdisciplinary collaborations. In nanotechnology, it serves as a building block for enzyme-responsive delivery vehicles that release payloads only upon encountering specific biomarkers like matrix metalloproteinases (Nano Letters, 2023). Meanwhile, synthetic biologists are exploring its use as a genetic circuit component for programmable cell signaling systems—a frontier highlighted at the 2023 International Conference on Synthetic Biology.

Economic modeling predicts sustained demand growth driven by expanding ADC pipelines and growing interest in precision diagnostics. Market analysis firm DelveInsight projects annual demand exceeding 5 metric tons globally by 2030 (DelveInsight Biopharma Report, Q1 2023), with North America accounting for over 45% of current consumption due to advanced healthcare infrastructure.

In conclusion, the CAS No. 6084-54-4 compound, or 1-(aminooxy)propane hydrochloride, stands at the intersection of cutting-edge chemical innovation and translational medicine. Its evolving applications—from targeted therapeutics to smart biomaterials—reflect ongoing advancements in synthetic methodology and interdisciplinary collaboration across academia and industry sectors.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)